The US Neurodegenerative Disease Market share is dominated by global pharmaceutical leaders and regional manufacturers offering innovative therapies. Major companies invest in R&D, clinical trials, and regulatory compliance to maintain competitive positioning. Market share depends on product portfolio diversity, therapeutic efficacy, and brand recognition. Emerging regional manufacturers...